Colorado was the first state to cap a drug’s price – then a federal court stepped in

The price cap would have lowered costs for Enbrel, an immunosuppressant drug made by Amgen.

By: Shweta Kumar, University of Kentucky, The Conversation

Outlets: The Conversation

Published: July 20, 2026

Words: 1,423

Last Updated: 1 month ago

Body Text Preview

By Shweta Kumar, University of Kentucky

Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set upper limits on what state agencies, insurers and other purchasers may pay or be reimbursed for certain high-cost drugs dispensed to patients in the state.

In fall 2025, the Colorado board capped Enbrel, an immunosuppressant drug made by Amgen used to …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us